Gland Pharma Ltd - 543245 - US FDA Inspection
US FDA Inspection26-08-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication26-08-2023
Gland Pharma Ltd - 543245 - Addendum To The Details Of The Statutory Auditor To Be Appointed (Item No 5 Of The Notice Of The AGM) At The 45Th AGM Of The Company
Addendum to the details of the Statutory Auditor to be appointed (Item No 5 of the Notice of the AGM) at the 45th AGM of the Company25-08-2023
Gland Pharma Ltd - 543245 - Conclusion Of US FDA Inspection At Dundigal Facility Of The Company
Conclusion of US FDA Inspection at Dundigal Facility of the Company24-08-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of the Investor Meeting23-08-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of the Investor Meetings21-08-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings Call Transcript for Q1FY2411-08-2023
Buy Gland Pharma; target of Rs 1560: Motilal Oswal
Motilal Oswal is bullish on Gland Pharma recommended buy rating on the stock with a target price of Rs 1560 in its research report dated August 07, 2023.10-08-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement pertaining to the Notice of the 45th Annual General Meeting of the Company10-08-2023
Gland Pharma Ltd - 543245 - Clarification In Regard To Increase In Volume Of Shares
Clarification in regard to increase in volume of shares09-08-2023